BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10940658)

  • 1. Increased general predisposition to cancer but not to specific neoplasms of the hematopoietic system in children with hematological neoplasms: a hypothesis.
    Roganovic J; Radojcic-Badovinac A
    Acta Haematol; 2000; 103(3):172-4. PubMed ID: 10940658
    [No Abstract]   [Full Text] [Related]  

  • 2. Second tumours.
    Meadows AT
    Eur J Cancer; 2001 Nov; 37(16):2074-9; discussion 2079-81. PubMed ID: 11597387
    [No Abstract]   [Full Text] [Related]  

  • 3. [Risk of cancer and malignant transformation in hematology practice].
    Várkonyi J
    Orv Hetil; 2002 Oct; 143(43):2435-8. PubMed ID: 12455145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML.
    Stelljes M; Corbacioglu A; Schlenk RF; Döhner K; Frühwald MC; Rossig C; Ehlert K; Silling G; Müller-Tidow C; Juergens H; Döhner H; Berdel WE; Kienast J; Koschmieder S
    Leukemia; 2011 Jul; 25(7):1209-10. PubMed ID: 21455213
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer predisposition syndromes.
    Weinstein JL; Ayyanar K; Watral MA
    Cancer Treat Res; 2009; 150():223-38. PubMed ID: 19834672
    [No Abstract]   [Full Text] [Related]  

  • 6. BRCA2 mutation and the risk of hematologic malignancy.
    Hall MJ; Li L; Wiernik PH; Olopade OI
    Leuk Lymphoma; 2006 Apr; 47(4):765-7. PubMed ID: 16886281
    [No Abstract]   [Full Text] [Related]  

  • 7. Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.
    Mangaonkar AA; Patnaik MM
    Mayo Clin Proc; 2020 Jul; 95(7):1482-1498. PubMed ID: 32571604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical cancer genetics: Part I: Gastrointestinal.
    Pollock J; Welsh JS
    Am J Clin Oncol; 2011 Jun; 34(3):332-6. PubMed ID: 20859198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal hematopoiesis and blood-cancer risk.
    Yan B; Ban K; Chng WJ
    N Engl J Med; 2015 Mar; 372(11):1071. PubMed ID: 25760362
    [No Abstract]   [Full Text] [Related]  

  • 10. Clonal hematopoiesis and blood-cancer risk.
    Genovese G; Jaiswal S; Ebert BL; McCarroll SA
    N Engl J Med; 2015 Mar; 372(11):1071-2. PubMed ID: 25760361
    [No Abstract]   [Full Text] [Related]  

  • 11. Clone wars--the emergence of neoplastic blood-cell clones with aging.
    Abkowitz JL
    N Engl J Med; 2014 Dec; 371(26):2523-5. PubMed ID: 25426835
    [No Abstract]   [Full Text] [Related]  

  • 12. Human genetics: somatic mutations linked to future disease risk.
    Burgess DJ
    Nat Rev Genet; 2015 Feb; 16(2):69. PubMed ID: 25534323
    [No Abstract]   [Full Text] [Related]  

  • 13. Metachronous T-Lymphoblastic Lymphoma and Burkitt Lymphoma in a Child With Constitutional Mismatch Repair Deficiency Syndrome.
    Alexander TB; McGee RB; Kaye EC; McCarville MB; Choi JK; Cavender CP; Nichols KE; Sandlund JT
    Pediatr Blood Cancer; 2016 Aug; 63(8):1454-6. PubMed ID: 27037742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating a CLL susceptibility variant in
    Blackburn NB; Marthick JR; Banks A; Charlesworth JC; Marsden KA; Lowenthal RM; Blangero J; Dickinson JL
    Blood; 2017 Jul; 130(1):86-88. PubMed ID: 28490571
    [No Abstract]   [Full Text] [Related]  

  • 15. [Genetic predisposition in children cancers in 2011].
    Gauthier-Villars M; Stoppa-Lyonnet D
    Bull Cancer; 2011 May; 98(5):459-75. PubMed ID: 21576046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. der(5;17)(p10;q10) is a recurrent but rare whole-arm translocation in patients with hematological neoplasms: a report of three cases.
    Manabe M; Okita J; Tarakuwa T; Harada N; Aoyama Y; Kumura T; Ohta T; Furukawa Y; Mugitani A
    Acta Haematol; 2014; 132(2):134-9. PubMed ID: 24556628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HemaExplorer: a Web server for easy and fast visualization of gene expression in normal and malignant hematopoiesis.
    Bagger FO; Rapin N; Theilgaard-Mönch K; Kaczkowski B; Jendholm J; Winther O; Porse B
    Blood; 2012 Jun; 119(26):6394-5. PubMed ID: 22745298
    [No Abstract]   [Full Text] [Related]  

  • 18. Discussing and managing hematologic germ line variants.
    Kohlmann W; Schiffman JD
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):309-315. PubMed ID: 27913496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD).
    Kitamura T; Watanabe-Okochi N; Enomoto Y; Nakahara F; Oki T; Komeno Y; Kato N; Doki N; Uchida T; Kagiyama Y; Togami K; Kawabata KC; Nishimura K; Hayashi Y; Nagase R; Saika M; Fukushima T; Asada S; Fujino T; Izawa Y; Horikawa S; Fukuyama T; Tanaka Y; Ono R; Goyama S; Nosaka T; Kitaura J; Inoue D
    J Biochem; 2016 Jan; 159(1):17-25. PubMed ID: 26590301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome.
    Ripperger T; Schlegelberger B
    Eur J Med Genet; 2016 Mar; 59(3):133-42. PubMed ID: 26743104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.